Business Context and Reporting Period
The provided filing is Brooks Automation, Inc.’s unaudited Form 10-Q for the quarter and nine months ended June 30, 2017, not an Azenta, Inc. filing. Brooks operated through Brooks Semiconductor Solutions Group and Brooks Life Science Systems, serving semiconductor capital equipment and life-science sample-management markets.
Financial Performance and Position
| Metric | Three months ended June 30, 2017 | Prior-year period | Nine months ended June 30, 2017 | Prior-year period |
|---|---|---|---|---|
| Revenue | $181.7 million | $147.5 million | $511.0 million | $402.8 million |
| Gross profit | $71.6 million | $54.2 million | $193.0 million | $141.5 million |
| Gross margin | 39.4% | 36.7% | 37.8% | 35.1% |
| Operating income | $18.8 million | $8.5 million | $46.7 million | $(6.2) million |
| Net income (loss) | $17.4 million | $8.6 million | $45.2 million | $(80.0) million |
| Diluted EPS | $0.25 | $0.12 | $0.64 | $(1.17) |
- Products generated $142.0 million of quarterly revenue and services generated $39.8 million. For the nine-month period, product revenue was $396.7 million and services revenue was $114.3 million.
- Quarterly segment revenue was $145.0 million for Semiconductor Solutions and $36.8 million for Life Science Systems. Nine-month segment revenue was $406.2 million and $104.8 million, respectively.
- Net cash provided by operating activities was $61.4 million for the nine months, compared with $16.1 million in the prior-year period. Capital expenditures were $6.8 million, dividends paid were $20.9 million, and net cash used in investing activities was $9.0 million.
- Cash and cash equivalents were $117.1 million; total cash, cash equivalents, and marketable securities were $119.7 million at June 30, 2017, compared with $91.2 million at September 30, 2016.
- The company had no borrowings under its $75.0 million senior secured revolving credit facility and reported approximately $56.5 million of availability. It was in compliance with covenants.
- Total liabilities were $157.0 million and stockholders’ equity was $589.8 million. The filing does not report conventional long-term debt outstanding.
- Quarterly dividend declared was $0.10 per share; $0.30 per share was declared for the first nine months.
Material Changes Versus the Prior Comparable Period
- Revenue increased 23% in the quarter and 27% for the nine months, with growth in both operating segments. Foreign exchange reduced year-over-year revenue comparisons by $1.1 million in the quarter and $3.1 million for the nine months.
- Gross margin expanded 2.7 percentage points in the quarter and 2.7 percentage points for the nine months, primarily reflecting higher operating leverage, product-cost improvements, and better semiconductor service productivity.
- Operating expenses increased 16% in the quarter but declined modestly for the nine months. Selling, general and administrative expense rose because of merger costs, employee-related costs, stock compensation, and amortization; research and development expense declined.
- Nine-month operating results improved from a $6.2 million operating loss to $46.7 million of operating income. The prior-year period included a $75.1 million tax provision largely related to establishing a valuation allowance against U.S. deferred tax assets.
- Restructuring charges declined to $0.8 million in the quarter and $2.7 million for the nine months, versus $1.0 million and $9.8 million, respectively, in the comparable periods. Remaining accrued restructuring costs were $1.7 million.
- On November 28, 2016, Brooks acquired Cool Lab for $15.2 million, including $4.8 million of cash and $10.3 million of non-cash consideration. Cool Lab contributed $2.5 million of nine-month revenue and a $0.3 million net loss.
Outlook, Commentary, Risks, and Unusual Items
- Management stated that available cash, operating cash flow, the revolving facility, and access to capital markets were expected to fund planned working capital, capital expenditures, and financing needs for the next twelve months. No specific earnings or revenue guidance was provided.
- Semiconductor demand is cyclical and can fluctuate significantly by quarter. Management identified customer spending, global economic conditions, foreign exchange, and the availability of financing as key uncertainties.
- Management expected restructuring actions to produce approximately $14.8 million of reduced annual cash spending when fully implemented. It also cited future annual pretax cost savings from completed or substantially completed actions.
- Revenue was expected to be reduced in fiscal 2017 by approximately $8.7 million from patent expirations and $13.0 million from exiting an atmospheric-robot distribution arrangement.
- On July 5, 2017, after quarter-end, Brooks agreed to acquire substantially all assets and liabilities of PBMMI’s biological-material storage and cold-chain logistics business for $34.3 million net of cash acquired, subject to working-capital adjustments. Purchase accounting was incomplete at the filing date.
- Approximately $71.0 million of cash was held outside the United States and management intended to permanently reinvest those funds abroad. Repatriation could create tax liabilities.
- Inventory purchase commitments were $112.8 million, letters of credit were approximately $3.4 million, and non-cancelable obligations under new Indianapolis leases totaled $2.4 million.
- Approximately 36,531 employee stock-purchase-plan shares could have been subject to rescission rights, with potential payments of up to approximately $0.3 million including estimated interest. The applicable rescission period expired July 31, 2017.
- Management reported no material changes to previously disclosed risk factors, no material adverse legal proceedings, effective disclosure controls, and no material changes in internal control over financial reporting.
Important Facts for Investors to Verify
- Confirm the issuer identity: the source text is Brooks Automation, Inc., whereas the request metadata identifies Azenta, Inc.
- Assess the sustainability of reported earnings after separating operating improvements from the prior-year tax valuation-allowance charge, acquisition-related items, equity-method earnings, restructuring benefits, and merger costs.
- Evaluate semiconductor-cycle exposure, customer concentration, foreign-exchange sensitivity, and the revenue effects of patent expirations and the discontinued distribution arrangement.
- Review the financing and liquidity impact of the $34.3 million PBMMI acquisition completed after quarter-end and any subsequent purchase-price-allocation adjustments.
- Monitor working-capital growth, particularly accounts receivable and inventories, against the $61.4 million of operating cash flow generated during the nine-month period.
- Verify the status and financial impact of the ESPP registration issue, restructuring liabilities, purchase commitments, letters of credit, and other contingencies.